SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt
Solesence, Inc. Common Stock Q2 2026 Earnings Call Summary
Solesence Inc (SLSN) (Q2 2026) Earnings Call Highlights: Strong Order Book Signals Record ...
Solésence Reports Second Quarter 2026 Financial Results
Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript
Solesence Reports Q2 2026 Results: Full Earnings Call Transcript
Solesence Q2 Sales $15.332M Down From $20.359M YoY
Solésence Reschedules Second Quarter 2026 Conference Call to August 19
Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11
SLSN Unveils Two Scalp Care Products Using Patented Technology
Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp
Solesence Launches Revitalizing Scalp Serum And Scalp Screen Dry Shampoo SPF 45+ Sunscreen
Solesence's Unit Enters Settlement Agreement With Refy Beauty On July 6, 2026; Co's Unit & Refy Agreed To Settle & Compromise Disputes Relating To Certain Consumer Care Products Previously Sold By Co's Unit To Refy; Unit To Pay Refy $938,000 In Twelve Installments Starting August 5, 2026
Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards
Solesence (SLSN) Q4 2025 Earnings Transcript
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs
Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition
Solesence Inc (SLSN) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
Gross Margin Expansion Highlights Solésence’s Operational Restructuring Efforts (SLSN)
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.